{'fraction_non_alphanumeric': 0.02336448598130841, 'fraction_numerical': 0.0035046728971962616, 'mean_word_length': 5.492424242424242, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
SHPA Standards of Practice for Drug Use Evaluation in Australian Hospitals: SHPA Committee of Specialty Practice in Drug Use Evaluation

INTRODUCTION Drug use evaluation (DUE) is a systematic quality improvement activity. The purpose of DUE is to improve the quality and cost-effectiveness of drug (medicine) use, and thereby improve patient care. DUE may be applied to a drug, therapeutic class, disease state or condition, a drug use process or specific outcomes.1 It may be applied in various practice settings, including hospitals, other health facilities, and community practice environments.2 DUE is an essential component of pharmacy service provision, clinical pharmacy practice and pharmacy quality assurance and management programs. These standards supersede the previously published SHP A Standards of Practice for DUE in Australian hospitals. 3